Skip to main content Skip to search Skip to main navigation
Martin Mayer
Author page

Martin Mayer

Vice President und Leiter des Competence Center Manufacturing Quality, Fresenius Kabi Deutschland GmbH.

Published articles

Quality Risk Management: What’s new in ICH Q9(R1)?

Quality Risk Management: What’s new in ICH Q9(R1)?

Do you trust your pills? Are you sure that nothing went wrong during production? Actually, you should be able to say yes, because medicinal products must be manufactured in such a way that they do not pose any risk to the patient through lack of safety, purity, quality or efficacy.

However, every step in the manufacturing process of medicinal products involves potential risks. Effective management, control and thus minimization of potential patient risks is only possible with the help of effective risk management.

The authoritative guideline for quality risk management, ICH Q9, has been revised. In today's editorial, you will find a summary of the most important changes in ICH Q9(R1).

Read more
Facts or Intuition – How Reliable is Your Risk Analysis?

Facts or Intuition – How Reliable is Your Risk Analysis?

How does subjectivity impact quality risk management? Martin Mayer discusses the dos and don'ts for an objective quality risk management.

Read more